FDA device listing

BD HLA-B27 Application Module,BD HLA-B27 Kit,BD HLA-B27 Software

FDA device listing 1163657443 · Becton Dickinson and Company

Key facts

Proprietary names BD HLA-B27 Application Module,BD HLA-B27 Kit,BD HLA-B27 Software
Owner/operator Becton Dickinson and Company
Owner/operator number 9922032
Premarket submissions BK050073
Product codes MZI
Device names MZI - Test, Qualitative, For Hla, Non-Diagnostic
Device class Unclassified
Classification regulations (21 CFR) ORCA1.MZI
Review panels Hematology
Registered establishments Becton, Dickinson and Company, BD Biosciences, Becton Dickinson Caribe, LTD
Establishment registrations 3008352382, 3027394506
FEI numbers 3008352382, 3027394506
Establishment operations Complaint File Establishment, Specification Developer, Contract Manufacturer
Registration valid through 2026

At a glance

  • 1–9 Registered establishments listing this device
  • None UDI devices (GUDID) under the same submission
  • 1–9 Device listings citing the same submission
  • Yes Premarket submission listed

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA device listings

Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.

Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database

Browse all FDA device listings